The stereochemistry of hydroxylation of the carotenoid lutein in Calendula officinalis

Excised, opening inflorescences of Calendula officinalis incorporated (3RS, 5R)- and (3RS, 5S)-[2-¹⁴C,5-³H₁]mevalonates into the carotenoid fraction. The ¹⁴C:³H ratios of lutein isolated from these tissues showed the hydrogen atom at C-3 of the β-ring is derived from the 5-pro-S position of mevalonate, while that at C-3 of the ε-ring is derived from the 5-pro-R position of mevalonate. Oxidation of lutein to monoketolutein showed that both hydrogen atoms at the C-15,15′ central double bond are derived from the 5-pro-R position of mevalonate.     

The conversion of (24S)-24-ethylcholesta-5,22,25-trien-3β-ol into poriferasterol,both in vivo and with a cell-free homogenate of the alga Trebouxia sp.

[6-³H₁] (24S)-24-Ethylcholesta-5,22,25-trien-3β-ol added to the growth medium of a culture of Trebouxia sp. 213/3 was efficiently taken-up by the cells and converted into (24R)-24-ethylcholesta-5,22-dien-3β-ol (poriferasterol) which is one of the major sterols of this alga. A cell-free homogenate was obtained from Trebouxia which catalysed the NADPH-dependent reduction of [6-³H₁] (24S)-24-ethylcholesta-5,22,25-trien-3β-ol to yield poriferasterol. The δ²⁵-sterol reductase was found to be mainly localized in the microsomal fraction of the homogenate.     

A family of titanium (IV) alkoxo complexes with N,O and O,O chelating ligands. Crystal structure of [Ti(O-i-Pr)2{2-(−)-menthoxo-pyridine}2]

In view of the wide applicability and versatility of titanium based Lewis acids in selective organic synthesis including asymmetric synthesis, we have synthesized a family of mono and polyatomic titanium derivatives. The polymetallic complexes prepared are bridged by pyridimine, quinone and triazine based ligands. The synthesis of [{Ti(O-i-Pr)₃(Oddbf)}₂] (1), [Ti(O-i-Pr)₂(Oddbf)₂] (2), [{Ti(O-i-Pr)₂(Oddbf)(OMent)}₂] (3) (ddbfO = 2,3-dihydro-2,2-dimethyl-benzofuranoxo; MentO = (1R,2S,5R)-(−)-menthoxo), [{Ti(O-i-Pr)₃(OMenpy)}₂] (4), [Ti(O-i-Pr)₂(OMenpy)₂] (5) (MenpyO = (1S,2S,5R)-(−)-menthoxo-pyridine); [{(Ti(OR)₃)₂L}_n] (RO = isopropoxo, (1R,2S,5R)-(−)-menthoxo) (6-11) and [{(Ti(O-i-Pr)₃)₃L}_n] (12) was accomplished from a Lewis acid such as Ti(O-i-Pr)₄, [{Ti(O-i-Pr)₃(OMent)}₂] or [Ti(OMent)₄] and chelating ligands (ddbfOH = 2,3-dihydro-2,2-dimethyl-benzofuranol; MenpyOH = (1R,2S,5R)-(−)-5-methyl-2-isopropyl-1-(2′-pyridinyl)cyclohexan-1-ol; LH₂ = 4,6-dihydroxy-2,5-diphenyl-pyrimidine, 2,4-dihydroxy-5,6-dimethyl-pyrimidine, 5,8-dihydroxy-1,4-napthoquinone, 2,5-dihydroxy-1,4-benzoquinone and LH₃ = cyanuric acid) that provide a rigid framework for the metal centre. The molecular structure of 5 has been determined by single crystal X-ray diffraction studies.     

Studies on the biosynthesis of the carane skeleton

Measurements of isotope ratios in car-3-ene biosynthesized in Pinus sylvestris from (3RS)-mevalonate-[2-¹⁴C,2R-³H₁], and [2-¹⁴C,4R-³H₁] and the corresponding S-epimers and also from geraniol- [¹⁴C,1-³H₂] and nerol-[¹⁴ C,1-³H₂] have shown that the carane skeleton is constructed from its presumed monocyclic precursor with migration of an olefinic bond, together with an unexpected 1,2-shift of a proton to the site of the original double bond. The detailed stereochemistry of the processes allows a two-step mechanism to be inferred for the cyclization in which a bonded intermediate is involved. The conversion of geraniol into nerol (en route to car-3-ene) probably is a redox process with the intermediacy of the corresponding aldehydes. The present results eliminate a possible mechanism for this isomerization wherein cyclopropane derivatives occur as intermediates.     

Stereoselective hydrogen abstraction in leukotriene A4 synthesis by purified 5-lipoxygenase of porcine leukocytes

Arachidonate 5-lipoxygenase purified from porcine leukocytes transformed arachidonic acid to 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid. By the leukotriene A synthase activity of the same enzyme the product was further metabolized to leukotriene A₄ (actually detected as 6-trans-leukotriene B₄, 12-epi-6-trans-leukotriene B₄, abd 5,6-duhydroxy-7,9,11,14-eicosatetraenoic acids). The enzyme was incubated with [10-D_R-³H]- or [10-L_S-³H]- labeled arachidonic acid, and 6-trans-LTB₄ and its 12-epimer were analyzed. More than 90% of 10-D_R-hydrogen was lost while about 100% of 10-L_S-hydrogen was retained, indicating a stereospecific hydrogen elimination from C-10 during the formation of leukotriene A₄.     

Asymmetric synthesis and effect of absolute stereochemistry of YCZ-2013, a brassinosteroid biosynthesis inhibitor

The four stereoisomers of 2RS,4RS-1-[[2-(2,4-dichlorophenyl)-4-(2-(2-propenyloxy)phenoxymethyl)-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (YCZ-2013), a novel brassinosteroid biosynthesis inhibitor, were prepared. The diastereomers of 2RS,4R-5 and 2RS,4S-5 were prepared by using the corresponding optically pure R and S toluene-4-sulfonic acid 2,3-dihydroxypropyl ester (R-4,S-4). The enatiomerically and diastereomerically pure acetonide (5) was obtained by a method involving diastereoselective crystallisation of the tosylate salt, followed by re-equilibration with the mother liquor and chromatography. The optical purity of four target compounds (YCZ-2013) was confirmed by chiral high-performance liquid chromatography (HPLC) and NMR. The effects of these stereoisomers on Arabidopsis stem elongation indicated that the cis isomers of 2S,4R-YCZ-2013 and 2R,4S-YCZ-2013 exhibited potent inhibitory activity with IC₅₀ values of approximately 24 ± 3 and 24 ± 2 nM, respectively. The IC₅₀ values of the trans isomers of 2S,4S-YCZ-2013 and 2R,4R-YCZ-2013 are approximately 1510 ± 50 and 3900 ± 332 nM, respectively. Co-application of brassinolide (10 nM), the most potent BR, and GA₃ (1 μM) to Arabidopsis seedlings grown in the dark with 2R,4S-YCZ-2013 and 2S,4R-YCZ-2013 revealed that brassinolide recovered the induced dwarfism of Arabidopsis seedlings, whereas GA₃ showed no effect.     

Preparation of Optically Active 2-Aminobutanoic Acid via Optical Resolution by Replacing Crystallization

An attempt was made to use a simple procedure to obtain (R)- and (S)-2-aminobutanoic acids [(R)- and (S)-1] which are non-proteinogenic α-amino acids and are useful as chiral reagents in asymmetric syntheses. Compound (RS)-1 p-toluenesulfonate [(RS)-2], which is known to exist as a conglomerate, was optically resolved by replacing crystallization with (R)- and (S)-methionine p-toluenesulfonate [(R)- and (S)-3] as optically active co-solutes. When (S)-3 was employed as the co-solute, (R)-2 was preferentially crystallized from a supersaturated solution of (RS)-2 in 1-propanol, as was (S)-2 in the presence of (R)-3. (R)- and (S)-2 recrystallized from 1-propanol were treated with triethylamine in methanol to give (R)- and (S)-1 in optically pure forms.     

25,26-dihydroxyvitamin D3 is not a major intermediate in 25-hydroxyvitamin D3-26,23-lactone formation

Structural similarities between 25S,26-dihydroxyvitamin D₃ and 25-hydroxyvitamin D₃-26,23-lactone and their concomitant multifold increase in the plasma of animals treated with pharmacological doses of vitamin D₃ suggest a precursor-product relationship. However, a single dose of 25S,26-[³H]dihydroxyvitamin D₃ given to rats treated chronically with pharmacological amounts of vitamin D₃ did not result in detectable plasma 25-[³H]hydroxyvitamin D₃-26,23-lactone. Multiple doses of synthetic 25S,26-dihydroxyvitamin D₃ given to vitamin D₃-deficient rats treated chronically with pharmacological amounts of vitamin D₂ also did not result in detectable plasma 25-hydroxyvitamin D₃-26,23-lactone. Furthermore, homogenates prepared from vitamin d-deficient chickens, dosed with 1,25-dihydroxyvitamin D₃, converted 25-[³H]hydroxyvitamin D₃ to 25-[³H]hydroxyvitamin D₃-26,23-lactone. But these same homogenates did not convert 25S,26-[³H]dihydroxyvitamin D₃ to 25-[³H]hydroxyvitamin D₃-26,23-lactone. These data indicate that 25,26-dihydroxyvitamin D₃ is not an intermediate in 25-hydroxyvitamin D₃26, 23-lactone formation.     

Chiral spin crossover iron(II) complex, fac-Λ-[Fe(HL)3](ClO4)2·EtOH (HL = 2-methylimidazol-4-yl-methylideneamino-R-(+)-1-methylphenyl)

A chiral spin crossover iron(II) complex, fac-Λ-[Fe^II(HL^R)₃](ClO₄)₂·EtOH was synthesized and its crystal structures in both the high-spin (HS) and low-spin (LS) states were determined, where HL^R denotes 2-methylimidazol-4-yl-methylideneamino-R-(+)-1-methylphenyl. The complex assumes octahedral coordination geometry of N₆ donor atoms by three bidentate ligands HL^R. The complex exists as the facial-Λ-isomer of fac-Λ-[Fe^II(HL^R)₃]²⁺ of the possible geometrical fac- and mer-isomers and the Δ- and Λ-enantiomorphs. The X-ray structural analyses revealed that the R-form of the ligand (HL^R) induces the fac-Λ-isomer of fac-Λ-[Fe^II(HL^R)₃]²⁺ and the S-form of the ligand (HL^S) induces the fac-Δ-isomer of fac-Δ-[Fe(HL^S)₃]²⁺. The complex fac-Λ-[Fe^II(HL^R)₃](ClO₄)₂·EtOH shows a complete steep spin crossover between the HS and the LS states at T_1/2 = 195 K.     

Stereochemical Control in the Still-Wittig Rearrangement Synthesis of Cyclohexyl (Z)-Alkene Inhibitors of Pin1

Three stereoisomeric inhibitors of Pin1: (2R,5S)-, (2S,5R)- and (2S,5S)-Ac–pSer–Ψ[(Z)CH = C]–pipecolyl(Pip)–2-(2-naphthyl)ethylamine 1, that mimic L-pSer–D-Pro, D-pSer–L-Pro, and D-pSer–D-Pro amides respectively, were synthesized by a 13-step route. The newly formed stereogenic centers in the pipecolyl ring were introduced by Luche reduction, followed by stereospecific [2,3]-Still-Wittig rearrangement. The (Z)- to (E)-alkene ratio in the rearrangements were consistently 5.5 to 1. The stereochemistry at the original Ser α-carbon controlled the stereochemistry of the Luche reduction, but it did not affect the stereochemical outcome of the rearrangement, which consistently gave the (Z)-alkene. The epimerized by-product, (2S,5S)-10, resulting from the work-up after Na/NH₃ debenzylation of (2S,5R)-9, was carried on to the (2S,5S)-1 isomer. Compound (2S,5S)-10 was resynthesized from the Luche reduction by-product, (2R,3R)-3, and the stereochemistry was confirmed by comparison of the optical rotations. The IC₅₀ values for (2R,5S)-1, (2S,5R)-1 and (2S,5S)-1 Pin1 inhibition were: 52, 85, and 140 μM, respectively.     

Biosynthesis of flavan-3-ols and other secondary plant products from (2S)phenylalanine

(2S)-Phenyl[2-¹⁴C,3R-³H₁]alanine and (2S)-phenyl[2-¹⁴C,3S-³H₁]alanine have been employed as substrates to study procyanidin and flavan-3-ol biosynthesis. Parallel studies with the cyanogenic glucosides prunasin and sambunigrin, Winterstein's acid [(3R)-3-dimethylaminophenylpropionic acid] and tropic acid show these to be derived by stereospecific processes from (2S)-phenylalanine. New proposals for procyanidin biosynthesis are briefly commented upon.     

Chiral metal complexes. 25. Cobalt(III) complexes of some linear mesomeric tetramine ligands

The complexes of Λ-α-[Co(R,S-picbn)Cl₂] ClO₄ (where R,S-picbn is 3R,4S-dimethyl-1,6-di(2-pyridyl)-2,5-diazahexane) together with its Δ-Λ-α and Δ,Λ-β exo congeners,Δ-Λ-β-exo-[Co(picchmn)Cl₂] ClO₄ (where picchmn is N,N'-di(2-picolyl)-1R, 2S-diaminocyclohexane) as well as Δ,Λ-β-endo-[Co(R,S-picstien)Cl₂] ClO₄·2H₂O, [Co(R,S-picstien)(ox)] ClO₄·0.5H₂O and [Co(R,S-picstien)(mal)] ClO₄·3H₂O (where picstien is 3R,4S-diphenyl-1,6-di(2-pyridyl)-2,5-diazahexane, ox is the oxalate dianion and mal is the malonate dianion) have been synthesised. The nature of the compounds was determined using a combination of ¹H NMR and, for certain chiral species, chiroptical techniques. In the various β complexes, the tetradentate is observed to adopt either the exo or endo geometry, specifically. Factors which influence coordination geometry include steric interactions and hydrophobic bonding effects.A number of chemical transformations between dinitro and dichloro complexes of Co(III) with R,S- picbn have been examined, as has the reaction of Δ,Λ-β-exo-[Co(R,S-picbn)Cl₂]⁺ with S-alanine in aqueous solution. The resulting product mixture contains eight of the sixteen possible β diastereoisomers, of which three have been isolated and characterised. The eight are composed of four β₁ and four β₂ isomers, however, and it is noted that isomerisation at the inplane amine nitrogen atom is restricted by the overall geometry of the complexes formed. Discriminatory forces in these complexes are small in magnitude, and exo/endo isomerisation is somewhat dependent upon the choice of ligand(s) used to complete the coordination sphere.     

Neolignans from an Aniba species

A benzene extract of the trunk of an Aniba species (Lauraceae) contained benzyl benzoate, benzyl salicylate, sitosterol and the neolignans (2S,3S,3aR)-3a-allyl-5-methoxy-3-methyl-2-piperonyl-2,3,3a,6-tetrahydro-6-oxobenzofuran (burchellin); (2S,3S,3aR)-3a-allyl-5-methoxy-3-methyl-2-veratryl-2,3,3a,6-tetrahydro-6-oxobenzofuran; (2S,3S,3aR)-3a-allyl-5,7-dimethoxy-3-methyl-2-veratryl-2,3,3a,6-tetrahydro-6-oxobenzofuran; (2S,3S,5S)-5-allyl-5-methoxy-3-methyl-2-veratryl-2,3,5,6-tetrahydro-6-oxo-benzofuran; (2R,3R)-7-methoxy-3-methyl-5-propenyl-2-veratryl-2,3-dihydrobenzofuran; rel-(1R,5R,6R,7R,8S)-1-allyl-8-hydroxy-3-methoxy-7-methyl-4-oxo-6-piperonylbicyclo[3,2,1]oct-2-ene (guianin); rel-(1S,5S,6S,7R,8R)-1-allyl-8-hydroxy-3,5-dimethoxy-7-methyl-4-oxo-6-piperonylbicyclo[3,2,1]oct-2-ene; rel-(1S,5S,6S,7R,8R)-8-acetoxy-1-allyl-3-hydroxy-5-methoxy-7-methyl-4-oxo-6-piperonyl-bicyclo[3,2,1]oct-2-ene; rel-1S,5S,6S,7R,8R)-8-acetoxy-3,5-dimethoxy-7-methyl-4-oxo-6-piperonylbicyclo[3,2,1]oct-2-ene; rel-(1R,5S,6R,7R)-1-allyl-3-methoxy-7-methyl-4,8-dioxo-6-piperonylbicyclo[3,2,1]oct-2-ene.     

Rubrenolide and rubrynolide: An alkene-alkyne pair from Nectandra rubra

Structures are proposed for rubrenolide, (2S,4R)-2-[(2′S)-2′,3′-dihydroxypropyl]-4-(dec-9′'-enyl)-γ-lactone, and rubrynolide, (2S,4R)-2-[(2′S)-2′,3′-dihydroxypropyl]-4-(dec-9′'-ynyl)-γ-lactone, isolated from Nectandra rubra (Lauraceae).     

Glycosylation of 2-phenylpropionic acid and its ethyl ester in suspension cultures of Nicotiana tabacum,Dioscoreophyllum cumminsii and Aconitum japonicum

Suspension cultures of Nicotiana tabacum and Dioscoreophyllum cumminsii converted 2-(RS)-phenylpropionic acid and its ethyl ester into 2-(RS)-phenylpropionyl β-D-glucopyranoside, 2-(RS)-phenylpropionyl 6-O-β-D-glucopyranosyl-β-D-glucopyranoside and 6-O-β-D- glucopyranosyl-2-O-[2-(RS)-phenylpropionyl]-D-glucose which accumulated in the cells. A suspension culture of Aconitum japonicum converted these substrates into ethyl 6-O-[2-(RS)-phenylpropionyl]- β-D-glucopyranoside which was mostly excreted into the medium. The diastereomeric mixture of the glucosyl esters of 2-(RS)-phenylpropionic acid was resolved by HPLC to show the ratio of R:S was 1:1.     

Stereochemical aspects of the conversion of cyclopeptine into dehydrocyclopeptine by cyclopeptine dehydrogenase from Penicillium cyclopium

Cyclopeptine dehydrogenase, an enzyme from Penicillium cyclopium, catalyses the reversible transformation of the benzodiazepine alkaloids cyclopeptine and dehydrocyclopeptine. By the dehydrogenation of cyclopeptine two hydrogen atoms are removed from the positions 3 and 10. It was demonstrated that, from the two optical isomers of cyclopeptine, only the naturally occurring 3S-compound was used as substrate by cyclopeptine dehydrogenase. To test the stereospecificity of the enzyme with respect to the second hydrogen which is eliminated from C-10 a mixture of cyclopeptine-3S-[10R-³H₁] and cyclopeptine-3R-10S-³H₁] was prepared. The 3S-isomer was transformed by the enzyme into radioactively labelled dehydrocyclopeptine. This demonstrated that cyclopeptine dehydrogenase removes the 10-proS hydrogen atom from the cyclopeptine molecule. Because the formed dehydrocyclopeptine has the trans-configuration it is probable that a synperiplanar elimination takes place. The hydride ion removed from cyclopeptine is transferred to the 4-proR-position of NAD⁺. Cyclopeptine dehydrogenase thus belongs to the A-specific dehydrogenases.     

Degradation of Benzo[a]pyrene by Mycobacterium vanbaalenii PYR-1

Metabolism of the environmental pollutant benzo[a]pyrene in the bacterium Mycobacterium vanbaalenii PYR-1 was examined. This organism initially oxidized benzo[a]pyrene with dioxygenases and monooxygenases at C-4,5, C-9,10, and C-11,12. The metabolites were separated by reversed-phase high-performance liquid chromatography (HPLC) and characterized by UV-visible, mass, nuclear magnetic resonance, and circular dichroism spectral analyses. The major intermediates of benzo[a]pyrene metabolism that had accumulated in the culture media after 96 h of incubation were cis-4,5-dihydro-4,5-dihydroxybenzo[a]pyrene (benzo[a]pyrene cis-4,5-dihydrodiol), cis-11,12-dihydro-11,12-dihydroxybenzo[a]pyrene (benzo[a]pyrene cis-11,12-dihydrodiol), trans-11,12-dihydro-11,12-dihydroxybenzo[a]pyrene (benzo[a]pyrene trans-11,12-dihydrodiol), 10-oxabenzo[def]chrysen-9-one, and hydroxymethoxy and dimethoxy derivatives of benzo[a]pyrene. The ortho-ring fission products 4-formylchrysene-5-carboxylic acid and 4,5-chrysene-dicarboxylic acid and a monocarboxylated chrysene product were formed when replacement culture experiments were conducted with benzo[a]pyrene cis-4,5-dihydrodiol. Chiral stationary-phase HPLC analysis of the dihydrodiols indicated that benzo[a]pyrene cis-4,5-dihydrodiol had 30% 4S,5R and 70% 4R,5S absolute stereochemistry. Benzo[a]pyrene cis-11,12-dihydrodiol adopted an 11S,12R conformation with 100% optical purity. The enantiomeric composition of benzo[a]pyrene trans-11,12-dihydrodiol was an equal mixture of 11S,12S and 11R,12R molecules. The results of this study, in conjunction with those of previously reported studies, extend the pathways proposed for the bacterial metabolism of benzo[a]pyrene. Our study also provides evidence of the stereo- and regioselectivity of the oxygenases that catalyze the metabolism of benzo[a]pyrene in M. vanbaalenii PYR-1.     

Bis(phosphine)-Pd(II) and -Pt(II) complexes containing chiral tetrazole-thiolato rings: Synthesis, structures, and reactivity toward some electrophiles

Bis(azido)bis(phosphine)-Pd(II) and -Pt(II) complexes, [M(N₃)₂L₂] {L = PMe₃, PEt₃, PMe₂Ph, dppe = 1,2-bis(diphenylphosphino)ethane}, underwent 1,3-dipolar cycloaddition with organic chiral isothiocyanates (R^∗-NCS: R^∗ = (S)-(+)-1-phenylethyl, (R)-(−)-1-phenylethyl, (±)-1-phenylethyl, (S)-(+)-1-indanyl) to give the corresponding tetrazole-thiolato Pd(II) and Pt(II) complexes, trans-[M{S[CN₄(R^∗)]}₂L₂] or [M{S[CN₄(R^∗)]}₂(dppe)]. Spectroscopic (IR and NMR) and X-ray structural analyses of the products showed that the absolute configuration of the starting organic isothiocyanates is retained throughout the reaction. Further treatments of the isolated tetrazole-thiolato complexes with electrophiles such as HCl or benzoyl chloride produced heterocyclic compounds containing a tetrazole thione or a tetrazolyl sulfide group. In addition, organic tetrazole thiones, [S = {CN₄H(R^∗)}] containing a chiral moiety, were prepared from NaN₃ and R^∗-NCS in the presence of water.     

Influence of glucose-templated proline mimetics on the β-turn conformation of the peptide fragment Ac-Leu-d-Phe-Pro-Val-NMe2 found in Gramicidin S

The synthesis of tetrapeptide-based β-turn mimetics containing spirocyclic glucose-templated 3-hydroxyproline hybrids Glc3′(S)-5′(R)(CH₂OH)HypH and Glc3′(S)-5′(S)(CH₂OH)HypH as proline mimetics is presented. NMR-based conformational analysis of Ac-Leu-d-Phe-[Glc3′(S)-5′(R)(CH₂OH)HypH]-Val-NMe₂ and Ac-Leu-d-Phe-[Glc3′(S)-5′(S)(CH₂OH)HypH]-Val-NMe₂ demonstrates the presence of β-turn conformations. Different turn structures were observed by changing the stereochemistry at 5′-position of Glc3′(S)-5′(R)(CH₂OH)HypH. The major prolyl amide cis isomer of glucose-protected tetrapeptide Ac-Leu-d-Phe-[Glc(MOM)₄3′(S)-5′(R)(CH₂OMOM)HypH]-Val-NMe₂11 and glucose unprotected Ac-Leu-d-Phe-[Glc3′(S)-5′(R)(CH₂OH)HypH]-Val-NMe₂13 forms a type VI β-turn conformation. In contrast, the major prolyl amide trans rotamer of tetrapeptide Ac-Leu-d-Phe-[Glc(MOM)₄3′(S)-5′(S)(CH₂OMOM)HypH]-Val-NMe₂12 conserves a similar β-turn conformation as the Gramicidin S-based peptide fragment Ac-Leu-d-Phe-Pro-Val-NMe₂16.     

Characterization of binding of [3H]PD 128907, A selective Dopamine D3 receptor agonist ligand,to CHO-K1 cells

PD 128907 [4a R, 10 b R-(+)-trans- 3, 4, 4a, 10 b - tetrahydro - 4- n-propy12 H,5H-[1] benzopyrano[4,3-b]1,4-oxazin-9-ol.], a selective dopamine (DA) D3 receptor agonist ligand exhibits about a 1000-fold selectivity for human D3 receptors (K_i, 1 nM) versus human D₂ receptors (K_i, 1183 nM) and a 10000-fold selectivity versus human D₄ receptors (K_i, 7000 nM) using [³H]spiperone as the radioligand in CHO-K1-cells. Studies with [³H]PD 128907, showed saturable, high affinity binding to human D₃ receptors expressed in CHO-K1 cells (CHO-K1-D₃) with an equilibrium dissociation constant (K_d) of 0.99 nM and a binding density (B_max) of 475 fmol/mg protein. Under the same conditions, there was no significant specific binding in CHO-K1-cells expressing human D₂ receptors (CHO-K1-D₂). The rank order of potency for inhibition of [³H]PD 128907 binding with reference DA agents was consistent with reported values for D₃ receptors. These results indicate that [³H]PD 128907 is a new, highly selective D₃ receptor ligand with high specific activity, high specific binding and low non-specific binding and therefore should be useful for further characterizing the DA D₃ receptors.